Vanguard Personalized Indexing Management, LLC Ab Cellera Biologics Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 12,468 shares of ABCL stock, worth $66,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,468
Previous 11,322
10.12%
Holding current value
$66,828
Previous $25,000
68.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ABCL
# of Institutions
148Shares Held
115MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$148 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$71.6 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$55.5 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$45.4 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$24.4 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.53B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...